Zacks Investment Research
21 Jul 2026, 16:50 UTC · 3h ago
Marsh Q2 Earnings Beat Estimates on Consulting Unit Strength
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
21 Jul 2026, 16:50 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Marsh & McLennan reported Q2 2026 adjusted EPS of $2.96, beating the Zacks Consensus Estimate by 2.8%. — An earnings beat typically supports a positive short-term price reaction for the specific stock.
+0.30Consolidated revenues rose 6.2% year over year to $7.4 billion, exceeding consensus estimates by 2%. — Strong top-line growth indicates healthy demand for the company's insurance and consulting services.
+0.20The Guy Carpenter unit's revenues fell 2% year over year to $664 million, missing the consensus mark by 4.4%. — Specific weakness and a miss in a key business unit suggests localized headwinds that could offset overall growth.
-0.20Continue reading
6 related stories
Top 1 mover · tap to explore
Total operating expenses increased 7% year over year to $5.5 billion, driven primarily by higher compensation and benefits costs. — Rising operational costs and wage pressure can compress margins and weigh on long-term profitability.
Which stocks this story touches
The company reported adjusted EPS and revenue that surpassed consensus estimates with year-over-year growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
3h ago
